Tiziana Life Sciences
Price & Volume
Stats
See more52W Range | $0.62-$1.91 |
Market Cap | $186.9M |
Shares Short | 596,494 |
Financials
See moreRevenue (12 Mos) | -$3.5M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.11 |
News
See moreYahoo Finance • 16 days ago
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center
Yahoo Finance • 16 days ago
Tiziana shares rise on presentation date for foralumab data
Yahoo Finance • 16 days ago
Tiziana Life Sciences to Present at the Bio International Convention
About
CEO | Dr. Ivor R. Elrifi Ph.D. |
CFO | Ms. Keeren Shah |
Address | 14/15 Conduit Street, London, United Kingdom, W1S 2XJ |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
